Azithromycin, ocular

Generic name
Azithromycin, ocular
Brand name
ATC Code
S01AA26

Azithromycin, ocular

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No data on use in children.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Bacterial conjunctivitis
  • Ocular
    • Term neonate
      [1]
      • 1 drop(s)/dose twice daily (in the morning and in the evening).
      • Duration of treatment:

        3 days

    • 1 month up to 18 years
      [1]
      • 1 drop(s)/dose twice daily (in the morning and in the evening).
      • Duration of treatment:

        3 days

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In neonates and infants of < 3 months, Chlamydia trachomatis can cause not only conjunctivitis but systemic infection (e.g. pneumonia); systemic treatment is necessary in such cases.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIINFECTIVES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Antibiotics
S01AA11
S01AA24
S01AA12
Antivirals
S01AD03
ANTIBIOTICS
S01AA11
S01AA24
S01AA12
ANTIVIRALS
S01AD03
Fluoroquinolones
S01AE07
S01AE01

Reference

  1. Laboratories Thea, SPC Azyter (RVG 34031) 1-8-2013, www.geneesmiddeleninformatiebank.nl, Geraadpleegd 28 okt 2016

Changes

Therapeutic Drug Monitoring


Overdose